NZ526748A - Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications - Google Patents

Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications

Info

Publication number
NZ526748A
NZ526748A NZ526748A NZ52674801A NZ526748A NZ 526748 A NZ526748 A NZ 526748A NZ 526748 A NZ526748 A NZ 526748A NZ 52674801 A NZ52674801 A NZ 52674801A NZ 526748 A NZ526748 A NZ 526748A
Authority
NZ
New Zealand
Prior art keywords
therapeutic
processes
preparation
compositions containing
bacterial strain
Prior art date
Application number
NZ526748A
Inventor
Mark Olshenitsky
Genadi Buchman
Original Assignee
Bio Balance Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/725,846 external-priority patent/US6500423B2/en
Application filed by Bio Balance Corp filed Critical Bio Balance Corp
Priority to NZ544366A priority Critical patent/NZ544366A/en
Publication of NZ526748A publication Critical patent/NZ526748A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84—Flavour masking or reducing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)

Abstract

A probiotic composition comprises a viable Escherichia coli strain BU-230-98 ATCC deposit No. 202226 (DSM 12799) and a formulation for maintaining the viability of the E.coli strain. The formulation includes at least one volatile fraction (VF) of a plant extract obtained by steam distillation of the plant extract under pressure lower than atmospheric pressure and at a bath temperature not exceeding 38oC and further wherein at least one volatile fraction is selected so as to sustain viability of as much as 107 cells/ml of the E.coli for at least two months at room temperature. The composition is useful for maintaining normal gastrointestinal microflora, treating gastro-enteric infection, the biocontrol of organisms, eliminating oil pollution and restoring organic fumes degrading microorganisms.
NZ526748A 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications NZ526748A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ544366A NZ544366A (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/725,846 US6500423B2 (en) 1999-06-03 2000-11-30 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
PCT/IL2001/001088 WO2002043649A2 (en) 2000-11-30 2001-11-27 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof

Publications (1)

Publication Number Publication Date
NZ526748A true NZ526748A (en) 2006-03-31

Family

ID=24916190

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ526748A NZ526748A (en) 2000-11-30 2001-11-27 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications

Country Status (14)

Country Link
EP (1) EP1343370A4 (en)
JP (1) JP4410992B2 (en)
KR (1) KR20030082549A (en)
CN (1) CN1294253C (en)
AU (2) AU2100402A (en)
BR (1) BR0116178A (en)
CA (1) CA2430292A1 (en)
IL (1) IL156213A0 (en)
MX (1) MXPA03004851A (en)
NZ (1) NZ526748A (en)
PL (1) PL366363A1 (en)
RU (1) RU2281326C2 (en)
WO (1) WO2002043649A2 (en)
ZA (1) ZA200304747B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212975D0 (en) * 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
IL152127A0 (en) 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
WO2005017095A2 (en) * 2003-08-18 2005-02-24 The Bio Balance Corporation A stable liquid probiotic composition, preparation and applications thereof
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
ATE526962T1 (en) * 2006-05-18 2011-10-15 Biobalance Llc BIOTHERAPEUTIC COMPOSITION CONTAINING PROBIOTIC ESCHERICHIA COLI AND METRONIDAZOLE AND USES THEREOF
RU2453320C2 (en) * 2008-08-05 2012-06-20 Виктор Владимирович Чалов Oral composition containing nonpathogenic microorganisms showing ability to normalise intestinal microflora (versions)
KR101127171B1 (en) * 2009-07-24 2012-03-20 (주)애드바이오텍 Composition of feed additives for ducks comprising egg yolk containing IgY against pathogen to induce acute and chronic infection disease
US20120183960A1 (en) 2010-12-07 2012-07-19 Enterologics, Inc. Method for identifying e. coli m-17
RU2458527C1 (en) * 2010-12-30 2012-08-20 Общество с ограниченной ответственностью "БИОТРОФ" Method for production of preparation for feeding farm animals and birds and method for preparation of fodder based on it
KR102171028B1 (en) 2012-07-20 2020-10-28 프레브테크 마이크로비아 인코포레이티드 Non-Pathogenic F18 E. Coli Strain and Use Thereof
ES2940463T3 (en) 2012-09-25 2023-05-08 Aquilon Cyl S L Probiotic and prebiotic compositions
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2953472A4 (en) * 2012-11-23 2017-03-01 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
CN105451561A (en) 2013-02-04 2016-03-30 赛里斯治疗公司 Compositions and methods
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
MX367109B (en) 2013-11-25 2019-08-05 Seres Therapeutics Inc Synergistic bacterial compositions and methods of production and use thereof.
WO2015095241A2 (en) 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
RU2660355C2 (en) * 2016-04-01 2018-07-05 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Antibacterial pharmaceutical composition for oral use containing bacteriophages
CN117898368A (en) * 2016-06-14 2024-04-19 Evah 营养公司 Animal feed pellets comprising feed additives, methods of making and using the same
RU2639544C1 (en) * 2016-12-16 2017-12-21 Общество с ограниченной ответственностью "БИОРЕАКТОР" Means for treatment and prevention of bird gastrointestinal tract diseases
EP3558296B1 (en) 2016-12-23 2023-06-28 Maregade RX, LLC Low dose product and method for treating diarrhea
CN107319103A (en) * 2017-08-01 2017-11-07 河南牧业经济学院 Promote feed addictive of growth of animals or poultry and intestinal growth and its preparation method and application
CN111212655A (en) 2017-08-14 2020-05-29 赛里斯治疗公司 Compositions and methods for treating cholestatic diseases
KR101939080B1 (en) * 2017-10-23 2019-01-16 고려대학교 산학협력단 Pseudomonas veronii strain KACC 81051BP and composition for comprising the same
CN109260235A (en) * 2018-10-23 2019-01-25 上海市第十人民医院 A kind of application of composition in preparation prevention and treatment constipation drug or health care product
CN110004072B (en) * 2018-11-12 2021-08-13 西安交通大学 Probiotic enterococcus faecalis isolate A3-1 and application thereof
CN113652340A (en) * 2021-08-24 2021-11-16 江苏江大源生态生物科技股份有限公司 Probiotic preparation, strain screening device and screening method
CN113616715B (en) * 2021-08-31 2022-05-06 昆明理工大学 Fermented traditional Chinese medicine oral liquid for treating piglet diarrhea and improving intestinal flora thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908028A (en) * 1973-04-19 1975-09-23 Procter & Gamble Soft drink composition containing paramethoxycinnamaldehyde as a flavoring agent and sweetner
GB1501098A (en) * 1974-06-11 1978-02-15 Brewing Patents Ltd Preparation of hop oil
US4986985A (en) * 1987-11-02 1991-01-22 Bar Ilan University Method of treating skin virus infections
CH675685A5 (en) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5082489A (en) * 1990-02-06 1992-01-21 The Royal Institution For The Advancement Of Learning (Mcgill University) Composition for biocontrol of wild buckwheat
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5486367A (en) * 1992-10-13 1996-01-23 Kansas State University Research Foundation Enzymatic method for accelerating fermentation of comestible products
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
AU714310B2 (en) * 1995-05-12 1999-12-23 Japan Pharmaceutical Development Co., Ltd Plant extract
CA2222563C (en) * 1995-05-26 2012-01-10 Ropapharm B.V. Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
US5679364A (en) * 1995-06-07 1997-10-21 Lee County Mosquito Control District Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments
GB2303799B (en) * 1995-07-29 1999-03-10 Siemens Plc Improvements in or relating to aqueous sample testing apparatus
US5888395A (en) * 1996-08-30 1999-03-30 The Regents Of The University Of California Method for enhanced longevity of in situ microbial filter used for bioremediation
US5773075A (en) * 1996-12-13 1998-06-30 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of Capsicum solids
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Also Published As

Publication number Publication date
ZA200304747B (en) 2004-09-03
MXPA03004851A (en) 2004-05-04
PL366363A1 (en) 2005-01-24
KR20030082549A (en) 2003-10-22
CN1494374A (en) 2004-05-05
BR0116178A (en) 2003-10-14
CN1294253C (en) 2007-01-10
WO2002043649A8 (en) 2004-04-29
WO2002043649A3 (en) 2002-08-29
CA2430292A1 (en) 2002-06-06
RU2281326C2 (en) 2006-08-10
EP1343370A2 (en) 2003-09-17
WO2002043649A2 (en) 2002-06-06
AU2002221004B2 (en) 2007-01-25
IL156213A0 (en) 2003-12-23
JP4410992B2 (en) 2010-02-10
JP2004534512A (en) 2004-11-18
AU2100402A (en) 2002-06-11
EP1343370A4 (en) 2004-02-11

Similar Documents

Publication Publication Date Title
NZ526748A (en) Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
West et al. Survival of Bacillus thuringiensis and Bacillus cereus spore inocula in soil: effects of pH, moisture, nutrient availability and indigenous microorganisms
Mouafi et al. Optimization of biosurfactant production by Bacillus brevis using response surface methodology
Hatvani Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture
Donio et al. Halomonas sp. BS4, A biosurfactant producing halophilic bacterium isolated from solar salt works in India and their biomedical importance
Souto et al. Genetic and functional characterization of a Bacillus sp. strain excreting surfactin and antifungal metabolites partially identified as iturin‐like compounds
Eggert Laccase-catalyzed formation of cinnabarinic acid is responsible for antibacterial activity of Pycnoporus cinnabarinus
Basit et al. Biosurfactants production potential of native strains of Bacillus cereus and their antimicrobial, cytotoxic and antioxidant activities.
HARRISON JR Genomic and physiological comparisons between heterotrophic thiobacilli and Acidiphilium cryptum, Thiobacillus versutus sp. nov., and Thiobacillus acidophilus nom. rev.
HK1043154A1 (en) A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
KR20050060624A (en) The novel bacillus amyloliquefaciens ktgb0202 and control method of plant pathogenic fungi using that
UA43366C2 (en) Pseudomonas chlororaphis strain ncimb 40616 or its pure cultures possessing the ability to produce antipathogenically active metabolites, composition for controlling plant diseases, method of controlling plant diseases
CN102296041A (en) Bacterium for efficiently degrading residual pesticide carbendazim and application thereof
AU4721399A (en) Methods and compositions for improving aerobic stability of silage
BR9507052A (en) Biofungicidal microorganism biofungicidal composition method to inhibit a fungal infection in a plant and method to separate a gungicidal microorganism from microbial samples
Winkelmann et al. Degradation of desferrioxamines by Azospirillum irakense: assignment of metabolites by HPLC/electrospray mass spectrometry
KR20180057235A (en) Method of biosurfactant using candida bombicola strain
CN102260641A (en) High-efficiency organic pollutant carbendazim degrading bacteria and use thereof
KR100252198B1 (en) Bacillus sp. strain with resistance against plant pathological fungi
Babu et al. Extraction of prodigiosin from Serratia marcescens and its application as an antibacterial spray
van Niekerk et al. The effect of carbon source on the growth and lipopeptide production of Bacillus circulans
KR101970656B1 (en) Novel Streptomyces lienomycini DS620 Strain and Antimicrobial Composition Comprising Extract Thereof
El-Naggar et al. Optimization of fermentation conditions for production of bioactive metabolites effective against Staphylococcus epidermidis by a newly isolated Nocardiopsis chromatogenes strain SH89 using the response surface methodology
KR101834760B1 (en) A newly isolated Sphingomonas sp. C8-2 strain for the detoxification of a chemical fungicide residue in soil and the detoxification method of the chemical fungicide residue in soil using this bacteria
KR102587464B1 (en) Antimicrobial decomposer comprising microorganism mixture having antimicrobial activity and decomposable activity of organic waste as effective component and uses thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)